GF Fund Management
HRMY icon

GF Fund Management’s Harmony Biosciences HRMY Stock Holding History

GF Fund Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$52.4K Buy
1,335
+108
+9% +$4.17K ﹤0.01% 389
2026
Q2 		$44.7K Sell
1,227
-67
-5% -$2.11K ﹤0.01% 400
2026
Q1 		$36.2K Buy
1,294
+163
+14% +$5.34K ﹤0.01% 436
2025
Q4 		$42.3K Sell
1,131
-107
-9% -$3.52K ﹤0.01% 420
2025
Q3 		$34.1K Sell
1,238
-222
-15% -$7.65K ﹤0.01% 434
2025
Q2 		$46.1K Hold
1,460
– – ﹤0.01% 424
2025
Q1 		$48.5K Buy
1,460
+262
+22% +$9.39K ﹤0.01% 423
2024
Q4 		$41.2K Buy
+1,198
New +$41.2K ﹤0.01% 408

Other funds holding HRMY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

GF Fund Management's HRMY Position: Q3 2026 in Review

GF Fund Management increased its Harmony Biosciences (HRMY) stake by 8.8% in Q3 2026, buying an estimated $4.17K and bringing the position to 1,335 shares worth $52.4K. The position accounts for ﹤0.01% of the portfolio, ranked #389.

GF Fund Management first reported a position in HRMY in Q4 2024 and has held it in 8 quarters since. 172 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • GF Fund Management held 1,335 shares of Harmony Biosciences worth $52.4K as of Q3 2026.
  • GF Fund Management bought 108 Harmony Biosciences shares in Q3 2026, an estimated $4.17K.
  • Harmony Biosciences made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #389 holding.
  • GF Fund Management first reported a position in Harmony Biosciences in Q4 2024 and has held it in 8 quarters since.
  • 172 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.